Janssen files Darzalex Faspro for rare disease light chain amyloidosis
Janssen has filed a new formulation of its Darzalex in the US for the rare and potentially fatal disease...
Read moreJanssen has filed a new formulation of its Darzalex in the US for the rare and potentially fatal disease...
Read moreSpringWorks Therapeutics, Inc. a clinical-stage biopharmaceutical company focused on developing life-chan...
Read moreIn the phase 3 OPTIMISMM trial, pomalidomide, bortezomib, and dexamethasone (PVd) demonstrated superior e...
Read moreAt the end of May, myeloma researchers would have flocked to Chicago for the 56th Annual Meeting of the A...
Read moreThe Janssen Pharmaceutical Companies of Johnson & Johnson announced today that Health Canada has approved...
Read moreGlobally, there are more than 18 million confirmed novel coronavirus infections. A question many have is...
Read moreJoin our community and sign up for our newsletter.